1-Epi-2-deoxyfortimicin B and derivatives

Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated via claimed linking group – bond – chelating agent,...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

536 17R, A61K 3171, C07H 1522

Patent

active

042822114

ABSTRACT:
1-Epi-2-deoxyfortimicin B and 4-N-derivatives thereof represented by the formula: ##STR1## wherein: R.sub.1 is hydrogen or loweralkyl and R.sub.2 is selected from the group consisting of loweralkyl, aminoloweralkyl, diaminoloweralkyl, N-loweralkylaminoloweralkyl, N,N-diloweralkylaminoloweralkyl, hydroxyloweralkyl, N-loweralkylaminohydroxyloweralkyl, N,N-diloweralkylaminoloweralkyl, acyl, aminoacyl, diaminoacyl, hydroxyacyl, hydroxy-substituted aminoacyl hydroxy-substituted diaminoacyl, N-loweralkylaminoacyl, N,N-diloweralkylaminoacyl, hydroxy-substituted-N-loweralkylaminoacyl or hydroxysubstituted N,N-diloweralkylaminoacyl with the limitation that R.sub.2 cannot be hydrogen glycyl, formylglycyl or hydantoyl, and the pharmaceutically acceptable salts thereof. The compounds are broad spectrum antibiotics.

REFERENCES:
patent: 4169198 (1979-09-01), Martin et al.
patent: 4176178 (1979-11-01), Martin et al.
patent: 4192867 (1980-03-01), Martin et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

1-Epi-2-deoxyfortimicin B and derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1-Epi-2-deoxyfortimicin B and derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-Epi-2-deoxyfortimicin B and derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-240111

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.